文献速递腹部CTMR

LI-RADS CT与MRI辅助征象对诊断性能的影响:个体参与者数据Meta分析

Impact of LI-RADS CT and MRI Ancillary Features on Diagnostic Performance: An Individual Participant Data Meta-Analysis.
PubMed 文献 · Radiology · 2025-01-01

本个体参与者数据Meta分析纳入46项研究、9257个观察(1098个CT、8159个MRI)来自7811名成人,评估应用单个LI-RADS辅助征象对CT与MRI诊断HCC性能的影响。结果显示,与仅用主要征象相比,应用任何单个辅助征象或将有利于HCC的辅助征象用于LR-4升级至LR-5,均未改变LI-RADS分类1-5的AUC及LR-5的PPV、敏感度和特异度。

要点

  • 应用单个LI-RADS辅助征象与仅用主要征象相比,LI-RADS分类1-5的AUC无差异(P值范围.65至>.99)。
  • LR-5的PPV、敏感度和特异度在仅用主要征象、加用单个辅助征象及允许升级策略间均无差异(P值范围.11至>.99)。
  • 仅纳入低偏倚风险研究(46项中9项)的敏感性分析结果与主分析一致。

核心结论

  • 应用单个LI-RADS辅助征象未影响CT与MRI LI-RADS的整体诊断性能,与仅用主要征象相比无差异。

研究设计与样本

  • 个体参与者数据Meta分析,检索2014年1月至2023年2月发表的评估成人HCC风险人群CT与MRI诊断准确性的研究,使用LI-RADS 2014、2017或2018版;纳入46项研究、9257个观察(1098个CT、8159个MRI)、7811名成人参与者(6792名男性,平均年龄58.7岁±10.7[SD]);采用双变量混合效应模型一步法汇总,参考标准为组织病理学分析或影像学复合参考标准。

诊断标准与关键数值

  • 比较三种策略:仅用主要征象;主要征象加用每个单个辅助征象;同策略2但允许有利于HCC或一般恶性的辅助征象将LR-4升级为LR-5;LI-RADS分类1-5的AUC及LR-5的PPV、敏感度、特异度在三种策略间均无差异(AUC比较P值范围.65至>.99;LR-5指标比较P值范围.11至>.99)。

临床应用与阅片要点

  • 原文结论为应用单个辅助征象未影响CT与MRI LI-RADS的整体诊断性能,与仅用主要征象相比无差异。

局限性

  • 仅纳入低偏倚风险研究的敏感性分析仅含46项研究中的9项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background A recent meta-analysis showed independent associations between most Liver Imaging Reporting and Data System (LI-RADS) ancillary features (AFs) and hepatocellular carcinoma (HCC), malignancy, and benignity. However, the impact of AFs on the diagnostic performance of LI-RADS remains unclear. Purpose To evaluate the impact of applying individual AFs on the diagnostic performance of CT and MRI LI-RADS using an individual participant data (IPD) meta-analysis. Materials and Methods Databases were searched for studies published from January 2014 to February 2023 that evaluated the diagnostic accuracy of CT and MRI for HCC in adults at risk for HCC using LI-RADS version 2014, 2017, or 2018. Observations were categorized according to LI-RADS major features, applying threshold growth when available, and excluding those previously treated or not meeting the composite reference standard (histopathologic analysis or imaging). Using a one-step approach, the IPD were pooled via bivariate mixed-effects models, accounting for clustering in participant-level and study-level random effects. The area under the receiver operator characteristic curve (AUC) for LI-RADS categories 1-5 and the positive predictive value (PPV), sensitivity, and specificity for LI-RADS category 5 (LR-5) observations were derived using three strategies: (a) major features only; (b) major features with each individual AF applied; and (c) similar to strategy 2 but allowing AFs favoring HCC in particular or malignancy in general to upgrade category LR-4 to category LR-5 when present. Comparisons were made using two-tailed z tests. Risk of bias was assessed using Quality Assessment of Diagnostic Accuracy Studies 2. Results Forty-six studies comprising 9257 observations (1098 CT, 8159 MRI) in 7811 adult participants (6792 male; mean age, 58.7 years ± 10.7 [SD]) were included. For all AFs, there were no differences in AUCs of LI-RADS categories 1-5 among strategies 1-3 (P value range, .65 to >.99). For category LR-5, there were also no differences among strategies 1-3 in the PPV, sensitivity, and specificity (P value range, .11 to >.99). Sensitivity analysis of only low-risk bias studies (nine of 46) yielded results consistent with primary analysis. Conclusion The application of individual AFs did not impact the overall diagnostic performance of CT and MRI LI-RADS compared with major features alone. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Searleman in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Abedrabbo N, Lam ET, McInnes MDF, et al. Impact of LI-RADS CT and MRI Ancillary Features on Diagnostic Performance: An Individual Participant Data Meta-Analysis. Radiology. 2025. PMID: 40626878. doi:10.1148/radiol.242278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。